Improved reduction of cardiovascular risk by bedtime ingestion of ARB and ACEI medication class therapies

Ramon C Hermida; Juan J. Crespo; Manuel Domínguez-Sardiña

doi:10.1093/eurheartj/ehaa214

Back

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2019

Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial

Ramon C Hermida, Juan J. Crespo, Manuel Domínguez-Sardiña, Alfonso Otero, Ana Moyá, María T. Ríos, Elvira Sineiro, M.C. Castiñeira, Pedro A. Callejas, Lorenzo Pousa, José Luis Bernal Salgado, Carmen Durán, Juan José García Sánchez, José R. Fernández, Artemio Mojón, Diana E. Ayala

Article2018

Risk of incident chronic kidney disease is better reduced by bedtime than upon-awakening ingestion of hypertension medications

Ramon C Hermida, Diana E. Ayala, Artemio Mojón, José R. Fernández

Article2011

Bedtime Dosing of Antihypertensive Medications Reduces Cardiovascular Risk in CKD

Ramon C Hermida, Diana E. Ayala, Artemio Mojón, José R. Fernández

Article2015

Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial

Ramon C Hermida, Diana E. Ayala, Artemio Mojón, José R. Fernández

Article2018

Hypertension: New perspective on its definition and clinical management by bedtime therapy substantially reduces cardiovascular disease risk

Ramon C Hermida, Diana E. Ayala, José R. Fernández, Artemio Mojón, Michael H. Smolensky